Back to today’s briefing

Story perspectives

Psychedelic Drug DOI Shows Promise Against Heroin Cravings

2/5/2025

29 3

Summary

Story summary

A groundbreaking study in Neuropharmacology reveals that the psychedelic drug DOI significantly curbed heroin cravings in rats by stimulating 5-HT2A receptors. This promising research hints at DOI's potential as a therapeutic ally in the battle against opioid addiction, though further exploration is needed to determine its effects on humans.

1 of 1

Story summary

A groundbreaking study in Neuropharmacology reveals that the psychedelic drug DOI significantly curbed heroin cravings in rats by stimulating 5-HT2A receptors. This promising research hints at DOI's potential as a therapeutic ally in the battle against opioid addiction, though further exploration is needed to determine its effects on humans.